Article Versions Notes

Deolankar MS, Carr RA, Fliorent R, Roh S, Fraimow H, Carabetta VJ. Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates. Antibiotics. 2022; 11(10):1298. https://doi.org/10.3390/antibiotics11101298

Deolankar, Manas S., Rachel A. Carr, Rebecca Fliorent, Sean Roh, Henry Fraimow, and Valerie J. Carabetta. 2022. "Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates" Antibiotics 11, no. 10: 1298. https://doi.org/10.3390/antibiotics11101298

Deolankar, M. S., Carr, R. A., Fliorent, R., Roh, S., Fraimow, H., & Carabetta, V. J. (2022). Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates. Antibiotics, 11(10), 1298. https://doi.org/10.3390/antibiotics11101298